We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $10.6B
1-Year Est. Return 19.39%
This Fund
S&P 500
This Quarter Est. Return
-1.03%
1 Year Est. Return
+19.39%
3 Year Est. Return
+79.14%
5 Year Est. Return
+100.61%
10 Year Est. Return
+428.16%
AUM
$9.72B
AUM Growth
-$1.65B
Cap. Flow
-$1.25B
Cap. Flow %
-12.9%
Top 10 Hldgs %
45.52%
Holding
79
New
3
Increased
10
Reduced
60
Closed
6
Avg Time Held
19.9 quarters
Top 10 Avg Time Held
9 quarters
Top 20 Avg Time Held
11 quarters

Top Buys

Rank Stock Value
1
RGA icon
Reinsurance Group of America
RGA
+$144M
2
RYAAY icon
Ryanair
RYAAY
+$80.8M
3
AZN icon
AstraZeneca
AZN
+$79.2M
4
NVDA icon
NVIDIA
NVDA
+$75.7M
5
CNI icon
Canadian National Railway
CNI
+$72M

Top Sells

Rank Stock Value
1
ALC icon
Alcon
ALC
+$382M
2
HDB icon
HDFC Bank
HDB
+$321M
3
TSM icon
TSMC
TSM
+$288M
4
ASML icon
ASML
ASML
+$117M
5
CME icon
CME Group
CME
+$75.7M

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Financials 17.66%
3 Industrials 12.4%
4 Communication Services 10.02%
5 Healthcare 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AVGO icon
26
Broadcom
AVGO
$1.73T
$118M 1.21%
381,392
-12,371
-3% -$4.07M
2021 Q2
19 quarters
SE icon
27
Sea Limited
SE
$58.3B
$113M 1.17%
1,368,108
-130,229
-9% -$14M
2025 Q3
2 quarters
PGR icon
28
Progressive
PGR
$126B
$113M 1.16%
570,524
-16,617
-3% -$3.43M
2025 Q2
3 quarters
APH icon
29
Amphenol
APH
$215B
$113M 1.16%
1,785,428
-123,290
-6% -$8.68M
2025 Q1
4 quarters
VEU icon
30
Vanguard FTSE All-World ex-US ETF
VEU
$68.3B
$105M 1.08%
1,399,374
-519,357
-27% -$40.2M
2017 Q3
34 quarters
V icon
31
Visa
V
$724B
$100M 1.03%
330,956
+91,369
+38% +$29.4M
2025 Q2
3 quarters
CME icon
32
CME Group
CME
$101B
$99.9M 1.03%
338,257
-255,021
-43% -$75.7M
2020 Q3
22 quarters
SLB icon
33
SLB Ltd
SLB
$72.6B
$97.3M 1%
1,892,813
+42,470
+2% +$2.06M
2013 Q2
51 quarters
HON icon
34
Honeywell
HON
$65.8B
$92.3M 0.95%
408,185
-29,913
-7% -$6.84M
2023 Q3
10 quarters
NVS icon
35
Novartis
NVS
$273B
$89.2M 0.92%
584,255
-19,132
-3% -$2.93M
2025 Q2
3 quarters
GMAB icon
36
Genmab
GMAB
$22.8B
$86.7M 0.89%
3,231,601
-138,542
-4% -$4.15M
2020 Q4
21 quarters
JNJ icon
37
Johnson & Johnson
JNJ
$630B
$86.2M 0.89%
352,800
-12,229
-3% -$2.85M
2025 Q2
3 quarters
AME icon
38
Ametek
AME
$57B
$81.2M 0.84%
378,705
-42,985
-10% -$9.55M
2025 Q1
4 quarters
AZN icon
39
AstraZeneca
AZN
$247B
$80.5M 0.83%
+410,787
New +$79.2M
2026 Q1
0 quarters
HEI icon
40
HEICO Corp
HEI
$41.7B
$78.9M 0.81%
287,673
+3,278
+1% +$1.06M
2025 Q1
4 quarters
BKNG icon
41
Booking.com
BKNG
$120B
$78.5M 0.81%
465,975
-344,250
-42% -$63.3M
2024 Q1
8 quarters
TLK icon
42
Telkom Indonesia
TLK
$12.6B
$78.4M 0.81%
4,199,301
-277,340
-6% -$5.66M
2021 Q1
20 quarters
ABBV icon
43
AbbVie
ABBV
$489B
$77.8M 0.8%
357,816
-13,017
-4% -$2.89M
2023 Q1
12 quarters
ACN icon
44
Accenture
ACN
$128B
$77.2M 0.79%
389,468
-20,047
-5% -$4.67M
2021 Q1
20 quarters
ADBE icon
45
Adobe
ADBE
$94.3B
$76.5M 0.79%
314,634
-13,850
-4% -$3.84M
2017 Q2
35 quarters
DE icon
46
Deere & Co
DE
$167B
$74.5M 0.77%
132,254
-10,089
-7% -$5.69M
2017 Q2
35 quarters
NVT icon
47
nVent Electric
NVT
$27.1B
$73.9M 0.76%
+624,667
New +$70.9M
2026 Q1
0 quarters
FN icon
48
Fabrinet
FN
$17.4B
$71.9M 0.74%
137,874
-1,813
-1% -$921K
2025 Q4
1 quarter
TMO icon
49
Thermo Fisher Scientific
TMO
$243B
$68.7M 0.71%
139,791
-5,234
-4% -$2.84M
2017 Q2
35 quarters
DHR icon
50
Danaher
DHR
$155B
$65.5M 0.67%
345,598
-15,325
-4% -$3.26M
2018 Q1
32 quarters
1
2
3 4

Similar funds

FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
VAS
Vestmark Advisory Solutions Wakefield, Massachusetts $10.6B AUM 25.02% 1-Year Est. Return
DPIM
Duff & Phelps Investment Management Chicago, Illinois $10.6B AUM 18.62% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $10.5B AUM 42.22% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $10.5B AUM 37.62% 1-Year Est. Return

Harding Loevner's Q1 2026 Portfolio in Review

As of Q1 2026, Harding Loevner held 79 positions worth $9.72B, down 14% from $11.4B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Harding Loevner withdrew a net $1.25B in Q1 2026, closing 6 positions and reducing 60 holdings. Its most notable exit was CoStar Group, an estimated $61.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Industrials.

Against the trend, Harding Loevner opened a new position in Reinsurance Group of America worth $142M.

  • Harding Loevner's largest Q1 2026 buy was Reinsurance Group of America: 696,797 shares worth $142M.
  • Harding Loevner added most to Ryanair in Q1 2026, an estimated $80.8M increase.
  • Harding Loevner's biggest Q1 2026 reduction was Alcon, cutting an estimated $382M.
  • Harding Loevner fully exited CoStar Group in Q1 2026, selling an estimated $61.9M.
  • Harding Loevner's ten largest holdings make up 46% of its $9.72B portfolio in Q1 2026.
  • Harding Loevner opened 3 new positions and closed 6 in Q1 2026.
  • Harding Loevner's portfolio value fell 14% quarter-over-quarter to $9.72B.

Based on Harding Loevner's 13F filing for Q1 2026, filed 15 May 2026.